If you are wondering whether Biogen’s current share price still offers value, or if the recent run has already priced in the good news, this article is for you. Biogen closed at US$185.63, with ...

Recent performance snapshot Biogen (BIIB) shares closed at US$171.59, with performance mixed across recent periods. The stock ...

The past six months have been a windfall for Biogen’s shareholders. The company’s stock price has jumped 41.7%, setting a new 52-week high of $188.65 per share. This was partly thanks to its solid ...

Biogen Inc. (BIIB) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for ...

Biogen (NASDAQ:BIIB) said its preliminary adjusted earnings per share for the fourth quarter of 2025 are expected to be about $1.26, below the consensus analyst forecast of $1.68. The biotechnology ...

Becton Dickinson shares closed at $186.05 on Wednesday. See how other analysts view this stock. Jefferies analyst Andrew Tsai initiated coverage on Biogen Inc. (NASDAQ: BIIB) with a Buy rating and ...

Biogen Inc. (BIIB) came out with quarterly earnings of $4.81 per share, beating the Zacks Consensus Estimate of $3.89 per share. This compares to earnings of $4.08 per share a year ago. These figures ...

(RTTNews) - Biogen Inc. (BIIB) expects its fourth-quarter 2025 results to include approximately $222 million in acquired in-process research and development (IPR&D), upfront, and milestone expenses on ...